feed,title,long_url,short_url
Benzinga,TCRÂ² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock,https://www.benzinga.com/pressreleases/21/01/g19228513/tcr-therapeutics-announces-pricing-of-public-offering-of-140-0-million-of-common-stock,https://j.mp/3quI1Cq
